메뉴 건너뛰기




Volumn 133, Issue 11, 2013, Pages 2512-2521

Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor

Author keywords

bioinformatics; genome wide analyses; microarrays; osteosarcoma; systems biology

Indexed keywords

GENOMIC DNA; GENOMIC RNA; MESSENGER RNA; MICRORNA; SOMATOMEDIN BINDING PROTEIN;

EID: 84884902907     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28124     Document Type: Review
Times cited : (71)

References (75)
  • 1
    • 0027939487 scopus 로고
    • Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes
    • Fletcher JA, Gebhardt MC, Kozakewich HP,. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes. Cancer Genet Cytogenet 1994; 77: 81-8.
    • (1994) Cancer Genet Cytogenet , vol.77 , pp. 81-88
    • Fletcher, J.A.1    Gebhardt, M.C.2    Kozakewich, H.P.3
  • 3
    • 0141799898 scopus 로고    scopus 로고
    • Mechanisms of sarcoma development
    • Helman LJ, Meltzer P,. Mechanisms of sarcoma development. Nat Rev Cancer 2003; 3: 685-94.
    • (2003) Nat Rev Cancer , vol.3 , pp. 685-694
    • Helman, L.J.1    Meltzer, P.2
  • 4
    • 68949192290 scopus 로고    scopus 로고
    • Prognostic factors and outcomes for osteosarcoma: An international collaboration
    • Pakos EE, Nearchou AD, Grimer RJ, et al. Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer 2009; 45: 2367-75.
    • (2009) Eur J Cancer , vol.45 , pp. 2367-2375
    • Pakos, E.E.1    Nearchou, A.D.2    Grimer, R.J.3
  • 5
    • 33846981552 scopus 로고    scopus 로고
    • Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup
    • Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99: 112-28.
    • (2007) J Natl Cancer Inst , vol.99 , pp. 112-128
    • Lewis, I.J.1    Nooij, M.A.2    Whelan, J.3
  • 6
    • 33646889372 scopus 로고    scopus 로고
    • Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials
    • Eselgrim M, Grunert H, Kuhne T, et al. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatr Blood Cancer 2006; 47: 42-50.
    • (2006) Pediatr Blood Cancer , vol.47 , pp. 42-50
    • Eselgrim, M.1    Grunert, H.2    Kuhne, T.3
  • 7
    • 80054914908 scopus 로고    scopus 로고
    • Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
    • Anninga JK, Gelderblom H, Fiocco M, et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 2011; 47: 2431-45.
    • (2011) Eur J Cancer , vol.47 , pp. 2431-2445
    • Anninga, J.K.1    Gelderblom, H.2    Fiocco, M.3
  • 8
    • 84862776906 scopus 로고    scopus 로고
    • Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
    • Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 481: 506-10.
    • (2012) Nature , vol.481 , pp. 506-510
    • Ding, L.1    Ley, T.J.2    Larson, D.E.3
  • 9
    • 84859722355 scopus 로고    scopus 로고
    • Bone: Conventional osteosarcoma
    • Mohseny AB,. Bone: conventional osteosarcoma. Atlas Genet Cytogenet Oncol Haematol 2008. (http://atlasgeneticsoncology.org/Tumors/ConvOsteoID5344.html).
    • (2008) Atlas Genet Cytogenet Oncol Haematol
    • Mohseny, A.B.1
  • 10
    • 0036275220 scopus 로고    scopus 로고
    • Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup
    • Hauben EI, Weeden S, Pringle J,et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002; 38: 1218-25.
    • (2002) Eur J Cancer , vol.38 , pp. 1218-1225
    • Hauben, E.I.1    Weeden, S.2    Pringle, J.3
  • 11
    • 32444446700 scopus 로고    scopus 로고
    • Clinico-histologic parameters of osteosarcoma patients with late relapse
    • Hauben EI, Bielack S, Grimer R, et al. Clinico-histologic parameters of osteosarcoma patients with late relapse. Eur J Cancer 2006; 42: 460-6.
    • (2006) Eur J Cancer , vol.42 , pp. 460-466
    • Hauben, E.I.1    Bielack, S.2    Grimer, R.3
  • 12
    • 79953000341 scopus 로고    scopus 로고
    • Concise review: Mesenchymal tumors: When stem cells go mad
    • Mohseny AB, Hogendoorn PCW,. Concise review: mesenchymal tumors: when stem cells go mad. Stem Cells 2011; 29: 397-403.
    • (2011) Stem Cells , vol.29 , pp. 397-403
    • Mohseny, A.B.1    Hogendoorn, P.C.W.2
  • 14
    • 33846910469 scopus 로고    scopus 로고
    • Sarcoma derived from cultured mesenchymal stem cells
    • Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371-9.
    • (2007) Stem Cells , vol.25 , pp. 371-379
    • Tolar, J.1    Nauta, A.J.2    Osborn, M.J.3
  • 15
    • 70350457821 scopus 로고    scopus 로고
    • Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2
    • Mohseny AB, Szuhai K, Romeo S, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009; 219: 294-305.
    • (2009) J Pathol , vol.219 , pp. 294-305
    • Mohseny, A.B.1    Szuhai, K.2    Romeo, S.3
  • 16
    • 84860681385 scopus 로고    scopus 로고
    • An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration
    • Mohseny AB, Xiao W, Carvalho R, et al. An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration. J Pathol 2012; 227: 245-53.
    • (2012) J Pathol , vol.227 , pp. 245-253
    • Mohseny, A.B.1    Xiao, W.2    Carvalho, R.3
  • 19
    • 34248582829 scopus 로고    scopus 로고
    • Cancer cell lines as genetic models of their parent histology: Analyses based on array comparative genomic hybridization
    • Greshock J, Nathanson K, Martin AM, et al. Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Res 2007; 67: 3594-600.
    • (2007) Cancer Res , vol.67 , pp. 3594-3600
    • Greshock, J.1    Nathanson, K.2    Martin, A.M.3
  • 20
    • 74949090294 scopus 로고    scopus 로고
    • Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet Effort
    • Ottaviano L, Schaefer KL, Gajewski M, et al. Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet Effort. Genes Chromosomes Cancer 2010; 49: 40-51.
    • (2010) Genes Chromosomes Cancer , vol.49 , pp. 40-51
    • Ottaviano, L.1    Schaefer, K.L.2    Gajewski, M.3
  • 21
    • 27644509946 scopus 로고    scopus 로고
    • Central high-grade osteosarcoma of bone: Diagnostic and genetic considerations
    • Cleton-Jansen AM, Buerger H, Hogendoom PCW,. Central high-grade osteosarcoma of bone: diagnostic and genetic considerations. Curr Diagn Pathol 2005; 11: 390-9.
    • (2005) Curr Diagn Pathol , vol.11 , pp. 390-399
    • Cleton-Jansen, A.M.1    Buerger, H.2    Hogendoom, P.C.W.3
  • 22
    • 0141705379 scopus 로고    scopus 로고
    • The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
    • Overholtzer M, Rao PH, Favis R, et al. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci USA 2003; 100: 11547-52.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 11547-11552
    • Overholtzer, M.1    Rao, P.H.2    Favis, R.3
  • 23
    • 79960909993 scopus 로고    scopus 로고
    • Functional characterization of osteosarcoma cell lines provides representative models to study the human disease
    • Mohseny AB, Machado I, Cai Y, et al. Functional characterization of osteosarcoma cell lines provides representative models to study the human disease. Lab Invest 2011; 91: 1195-205.
    • (2011) Lab Invest , vol.91 , pp. 1195-1205
    • Mohseny, A.B.1    Machado, I.2    Cai, Y.3
  • 24
    • 77957554389 scopus 로고    scopus 로고
    • A tissue microarray study of osteosarcoma: Histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models
    • Mayordomo E, Machado I, Giner F, et al. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models. Appl Immunohistochem Mol Morphol 2010; 18: 453-61.
    • (2010) Appl Immunohistochem Mol Morphol , vol.18 , pp. 453-461
    • Mayordomo, E.1    Machado, I.2    Giner, F.3
  • 25
    • 84855482786 scopus 로고    scopus 로고
    • Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
    • Kresse SH, Meza-Zepeda LA, Machado I, et al. Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations. Cancer 2012; 118: 558-70.
    • (2012) Cancer , vol.118 , pp. 558-570
    • Kresse, S.H.1    Meza-Zepeda, L.A.2    Machado, I.3
  • 26
    • 0024359778 scopus 로고
    • C-fos Expression induces bone tumors in transgenic mice
    • Ruther U, Komitowski D, Schubert FR, et al. c-fos Expression induces bone tumors in transgenic mice. Oncogene 1989; 4: 861-5.
    • (1989) Oncogene , vol.4 , pp. 861-865
    • Ruther, U.1    Komitowski, D.2    Schubert, F.R.3
  • 27
    • 45349086509 scopus 로고    scopus 로고
    • Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
    • Walkley CR, Qudsi R, Sankaran VG, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008; 22: 1662-76.
    • (2008) Genes Dev , vol.22 , pp. 1662-1676
    • Walkley, C.R.1    Qudsi, R.2    Sankaran, V.G.3
  • 28
    • 80053173117 scopus 로고    scopus 로고
    • MRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
    • Kuijjer ML, Namløs HM, Hauben EI, et al. mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts. BMC Research Notes 2011; 4: 66.
    • (2011) BMC Research Notes , vol.4 , pp. 66
    • Kuijjer, M.L.1    Namløs, H.M.2    Hauben, E.I.3
  • 29
    • 84855482786 scopus 로고    scopus 로고
    • Preclinical xenograft models of human sarcoma show non-random loss of aberrations
    • Kresse SH, Meza-Zepeda LA, Machado I, et al. Preclinical xenograft models of human sarcoma show non-random loss of aberrations. Cancer 2012; 118: 558-70.
    • (2012) Cancer , vol.118 , pp. 558-570
    • Kresse, S.H.1    Meza-Zepeda, L.A.2    Machado, I.3
  • 30
    • 79959503826 scopus 로고    scopus 로고
    • The International HapMap Project
    • The International HapMap Project. Nature 2003; 426: 789-96.
    • (2003) Nature , vol.426 , pp. 789-796
  • 31
    • 79954573473 scopus 로고    scopus 로고
    • Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: A rationale for treatment with macrophage- activating agents
    • Buddingh EP, Kuijjer ML, Duim RA, et al. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents. Clin Cancer Res 2011; 17: 2110-9.
    • (2011) Clin Cancer Res , vol.17 , pp. 2110-2119
    • Buddingh, E.P.1    Kuijjer, M.L.2    Duim, R.A.3
  • 32
    • 80052703371 scopus 로고    scopus 로고
    • Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma
    • Su Y, Wagner ER, Luo Q, et al. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 2011; 30: 3907-17.
    • (2011) Oncogene , vol.30 , pp. 3907-3917
    • Su, Y.1    Wagner, E.R.2    Luo, Q.3
  • 33
    • 70649090109 scopus 로고    scopus 로고
    • Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
    • Cleton-Jansen AM, Anninga JK, Briaire-de Bruijn I, et al. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 2009; 101: 2064.
    • (2009) Br J Cancer , vol.101 , pp. 2064
    • Cleton-Jansen, A.M.1    Anninga, J.K.2    Briaire-De Bruijn, I.3
  • 34
    • 84858116745 scopus 로고    scopus 로고
    • Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
    • Namløs HM, Kresse SH, Muller CR, et al. Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. Sarcoma 2012; 2012: 639038.
    • (2012) Sarcoma , vol.2012 , pp. 639038
    • Namløs, H.M.1    Kresse, S.H.2    Muller, C.R.3
  • 35
    • 0031943038 scopus 로고    scopus 로고
    • Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: Study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin
    • Bacci G, Ferrari S, Delepine N, et al. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol 1998; 16: 658-63.
    • (1998) J Clin Oncol , vol.16 , pp. 658-663
    • Bacci, G.1    Ferrari, S.2    Delepine, N.3
  • 37
    • 33644505791 scopus 로고    scopus 로고
    • Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution
    • Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy-15-year experience in 789 patients treated at a single institution. Cancer 2006; 106: 1154-61.
    • (2006) Cancer , vol.106 , pp. 1154-1161
    • Bacci, G.1    Longhi, A.2    Versari, M.3
  • 38
    • 33846978784 scopus 로고    scopus 로고
    • Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting
    • Dupuy A, Simon RM,. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 2007; 99: 147-57.
    • (2007) J Natl Cancer Inst , vol.99 , pp. 147-157
    • Dupuy, A.1    Simon, R.M.2
  • 39
    • 70350453743 scopus 로고    scopus 로고
    • Relative power and sample size analysis on gene expression profiling data
    • van Iterson M, 't Hoen, PA, Pedotti, P, et al. Relative power and sample size analysis on gene expression profiling data. BMC Research Notes 2009; 10: 439.
    • (2009) BMC Research Notes , vol.10 , pp. 439
    • Hoen Van Iterson M, '.T.1    Pedotti, P.A.P.2
  • 40
    • 78650349223 scopus 로고    scopus 로고
    • Do predictive signatures really predict response to cancer chemotherapy?
    • Borst P, Wessels L,. Do predictive signatures really predict response to cancer chemotherapy? Cell Cycle 2010; 9: 4836-40.
    • (2010) Cell Cycle , vol.9 , pp. 4836-4840
    • Borst, P.1    Wessels, L.2
  • 41
    • 73149111923 scopus 로고    scopus 로고
    • Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
    • Bruheim S, Xi Y, Ju J, et al. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Clin Cancer Res 2009; 15: 7161-9.
    • (2009) Clin Cancer Res , vol.15 , pp. 7161-7169
    • Bruheim, S.1    Xi, Y.2    Ju, J.3
  • 42
    • 7044226340 scopus 로고    scopus 로고
    • Human osteosarcoma xenografts and their sensitivity to chemotherapy
    • Bruheim S, Bruland OS, Breistol K, et al. Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res 2004; 10: 133-41.
    • (2004) Pathol Oncol Res , vol.10 , pp. 133-141
    • Bruheim, S.1    Bruland, O.S.2    Breistol, K.3
  • 43
    • 65549107328 scopus 로고    scopus 로고
    • Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling
    • Sadikovic B, Yoshimoto M, Chilton-MacNeill S, et al. Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol Genet 2009; 18: 1962-75.
    • (2009) Hum Mol Genet , vol.18 , pp. 1962-1975
    • Sadikovic, B.1    Yoshimoto, M.2    Chilton-Macneill, S.3
  • 44
    • 84860662550 scopus 로고    scopus 로고
    • Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
    • Kuijjer ML, Rydbeck H, Kresse SH, et al. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Genes Chromosomes Cancer 2012; 51: 696-706.
    • (2012) Genes Chromosomes Cancer , vol.51 , pp. 696-706
    • Kuijjer, M.L.1    Rydbeck, H.2    Kresse, S.H.3
  • 45
    • 65249167488 scopus 로고    scopus 로고
    • Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
    • Kansara M, Tsang M, Kodjabachian L, et al. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest 2009; 119: 837-51.
    • (2009) J Clin Invest , vol.119 , pp. 837-851
    • Kansara, M.1    Tsang, M.2    Kodjabachian, L.3
  • 46
    • 84859386766 scopus 로고    scopus 로고
    • MiRNA signatures associate with pathogenesis and progression of osteosarcoma
    • Jones KB, Salah Z, Del MS, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72: 1865-77.
    • (2012) Cancer Res , vol.72 , pp. 1865-1877
    • Jones, K.B.1    Salah, Z.2    Del, M.S.3
  • 47
    • 84868110139 scopus 로고    scopus 로고
    • Modulation of the osteosarcoma expression phenotype by microRNAs
    • Namløs HM, Meza-Zepeda LA, Baroy T, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 2012; 7: e48086.
    • (2012) PLoS One , vol.7
    • Namløs, H.M.1    Meza-Zepeda, L.A.2    Baroy, T.3
  • 48
    • 77951791258 scopus 로고    scopus 로고
    • S-MED: Sarcoma microRNA expression database
    • Sarver AL, Phalak R, Thayanithy V, et al. S-MED: sarcoma microRNA expression database. Lab Invest 2010; 90: 753-61.
    • (2010) Lab Invest , vol.90 , pp. 753-761
    • Sarver, A.L.1    Phalak, R.2    Thayanithy, V.3
  • 49
    • 50949113230 scopus 로고    scopus 로고
    • In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma
    • Sadikovic B, Yoshimoto M, Al-Romaih K, et al. In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma. PLoS One 2008; 3: e2834.
    • (2008) PLoS One , vol.3
    • Sadikovic, B.1    Yoshimoto, M.2    Al-Romaih, K.3
  • 50
    • 84868128368 scopus 로고    scopus 로고
    • Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma
    • Kresse SH, Rydbeck H, Skarn M, et al. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. PLoS One 2012; 7: e48262.
    • (2012) PLoS One , vol.7
    • Kresse, S.H.1    Rydbeck, H.2    Skarn, M.3
  • 51
    • 0141889935 scopus 로고    scopus 로고
    • High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays
    • Squire JA, Pei J, Marrano P, et al. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 2003; 38: 215-25.
    • (2003) Genes Chromosomes Cancer , vol.38 , pp. 215-225
    • Squire, J.A.1    Pei, J.2    Marrano, P.3
  • 52
    • 13144300881 scopus 로고    scopus 로고
    • Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
    • Man TK, Lu XY, Jaeweon K, et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Research Notes 2004; 7: 45.
    • (2004) BMC Research Notes , vol.7 , pp. 45
    • Man, T.K.1    Lu, X.Y.2    Jaeweon, K.3
  • 53
    • 19944427138 scopus 로고    scopus 로고
    • Gene amplifications in osteosarcoma-CGH microarray analysis
    • Atiye J, Wolf M, Kaur S, et al. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 2005; 42: 158-63.
    • (2005) Genes Chromosomes Cancer , vol.42 , pp. 158-163
    • Atiye, J.1    Wolf, M.2    Kaur, S.3
  • 54
    • 80053237717 scopus 로고    scopus 로고
    • Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma
    • Yang J, Yang D, Sun Y, et al. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer 2011; 117: 4925-38.
    • (2011) Cancer , vol.117 , pp. 4925-4938
    • Yang, J.1    Yang, D.2    Sun, Y.3
  • 55
    • 67650465624 scopus 로고    scopus 로고
    • LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
    • Kresse SH, Ohnstad HO, Paulsen EB, et al. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 2009; 48: 679-93.
    • (2009) Genes Chromosomes Cancer , vol.48 , pp. 679-693
    • Kresse, S.H.1    Ohnstad, H.O.2    Paulsen, E.B.3
  • 56
    • 79954965424 scopus 로고    scopus 로고
    • Cyclin E1 is amplified and overexpressed in osteosarcoma
    • Lockwood WW, Stack D, Morris T, et al. Cyclin E1 is amplified and overexpressed in osteosarcoma. J Mol Diagn 2011; 13: 289-96.
    • (2011) J Mol Diagn , vol.13 , pp. 289-296
    • Lockwood, W.W.1    Stack, D.2    Morris, T.3
  • 57
    • 70449359177 scopus 로고    scopus 로고
    • Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma
    • Yen CC, Chen WM, Chen TH, et al. Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. Int J Oncol 2009; 35: 775-88.
    • (2009) Int J Oncol , vol.35 , pp. 775-788
    • Yen, C.C.1    Chen, W.M.2    Chen, T.H.3
  • 58
    • 77956248437 scopus 로고    scopus 로고
    • Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
    • Kresse SH, Szuhai K, Barragan-Polania AH, et al. Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours. BMC Research Notes 2010; 3: 223.
    • (2010) BMC Research Notes , vol.3 , pp. 223
    • Kresse, S.H.1    Szuhai, K.2    Barragan-Polania, A.H.3
  • 59
    • 77955744323 scopus 로고    scopus 로고
    • Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma
    • Smida J, Baumhoer D, Rosemann M, et al. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res 2010; 16: 4256-67.
    • (2010) Clin Cancer Res , vol.16 , pp. 4256-4267
    • Smida, J.1    Baumhoer, D.2    Rosemann, M.3
  • 60
    • 75149191872 scopus 로고    scopus 로고
    • Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma
    • Pasic I, Shlien A, Durbin AD, et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 2010; 70: 160-71.
    • (2010) Cancer Res , vol.70 , pp. 160-171
    • Pasic, I.1    Shlien, A.2    Durbin, A.D.3
  • 62
    • 0345714858 scopus 로고    scopus 로고
    • Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
    • Lau CC, Harris CP, Lu XY, et al. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004; 39: 11-21.
    • (2004) Genes Chromosomes Cancer , vol.39 , pp. 11-21
    • Lau, C.C.1    Harris, C.P.2    Lu, X.Y.3
  • 63
    • 41349122898 scopus 로고    scopus 로고
    • Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes
    • Lee H, Kong SW, Park PJ,. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes. Bioinformatics 2008; 24: 889-96.
    • (2008) Bioinformatics , vol.24 , pp. 889-896
    • Lee, H.1    Kong, S.W.2    Park, P.J.3
  • 64
    • 84865378998 scopus 로고    scopus 로고
    • MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma
    • Baumhoer D, Zillmer S, Unger K, et al. MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet 2012; 205: 212-9.
    • (2012) Cancer Genet , vol.205 , pp. 212-219
    • Baumhoer, D.1    Zillmer, S.2    Unger, K.3
  • 65
    • 73649132981 scopus 로고    scopus 로고
    • Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma
    • Cai Y, Mohseny AB, Karperien M, et al. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 2010; 220: 24-33.
    • (2010) J Pathol , vol.220 , pp. 24-33
    • Cai, Y.1    Mohseny, A.B.2    Karperien, M.3
  • 66
    • 36049042525 scopus 로고    scopus 로고
    • Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway
    • Matushansky I, Hernando E, Socci ND, et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 2007; 117: 3248-57.
    • (2007) J Clin Invest , vol.117 , pp. 3248-3257
    • Matushansky, I.1    Hernando, E.2    Socci, N.D.3
  • 67
    • 79961020791 scopus 로고    scopus 로고
    • Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1
    • Malinauskas T, Aricescu AR, Lu W, et al. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 2011; 18: 886-93.
    • (2011) Nat Struct Mol Biol , vol.18 , pp. 886-893
    • Malinauskas, T.1    Aricescu, A.R.2    Lu, W.3
  • 68
    • 84861307078 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3beta, NF-kappaB signaling, and tumorigenesis of human osteosarcoma
    • Tang QL, Xie XB, Wang J, et al. Glycogen synthase kinase-3beta, NF-kappaB signaling, and tumorigenesis of human osteosarcoma. J Natl Cancer Inst 2012; 104: 749-63.
    • (2012) J Natl Cancer Inst , vol.104 , pp. 749-763
    • Tang, Q.L.1    Xie, X.B.2    Wang, J.3
  • 69
    • 79955964176 scopus 로고    scopus 로고
    • High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A
    • Vijayakumar S, Liu G, Rus IA, et al. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A. Cancer Cell 2011; 19: 601-12.
    • (2011) Cancer Cell , vol.19 , pp. 601-612
    • Vijayakumar, S.1    Liu, G.2    Rus, I.A.3
  • 70
    • 84869488840 scopus 로고    scopus 로고
    • The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma
    • Mohseny AB, Cai Y, Kuijjer M, et al. The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma. Eur J Cancer 2012; 48: 3429-38.
    • (2012) Eur J Cancer , vol.48 , pp. 3429-3438
    • Mohseny, A.B.1    Cai, Y.2    Kuijjer, M.3
  • 72
    • 13344270394 scopus 로고
    • Adjuvant therapy for osteosarcoma in dogs: Results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin
    • Kurzman ID, MacEwen EG, Rosenthal RC, et al. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res 1995; 1: 1595-601.
    • (1995) Clin Cancer Res , vol.1 , pp. 1595-1601
    • Kurzman, I.D.1    Macewen, E.G.2    Rosenthal, R.C.3
  • 73
    • 39149136228 scopus 로고    scopus 로고
    • Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
    • Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group. J Clin Oncol 2008; 26: 633-8.
    • (2008) J Clin Oncol , vol.26 , pp. 633-638
    • Meyers, P.A.1    Schwartz, C.L.2    Krailo, M.D.3
  • 74
    • 78650959663 scopus 로고    scopus 로고
    • Massive genomic rearrangement acquired in a single catastrophic event during cancer development
    • Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144: 27-40.
    • (2011) Cell , vol.144 , pp. 27-40
    • Stephens, P.J.1    Greenman, C.D.2    Fu, B.3
  • 75
    • 78650539308 scopus 로고    scopus 로고
    • From RNA-seq reads to differential expression results
    • Oshlack A, Robinson MD, Young MD,. From RNA-seq reads to differential expression results. Genome Biol 2010; 11: 220.
    • (2010) Genome Biol , vol.11 , pp. 220
    • Oshlack, A.1    Robinson, M.D.2    Young, M.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.